Viral infections in patients with malignant diseases.
D000818:Animals; D000917:Antibody Formation; D000998:Antiviral Agents / Q000627:therapeutic use; D006689:Hodgkin Disease / Q000150:complications; D006801:Humans; D007111:Immunity, Cellular; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007372:Interferons; D009369:Neoplasms / Q000150:complications* / Q000276:immunology; D014777:Virus Diseases / Q000150:complications* / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000628:therapy; D005719:gamma-Globulins / Q000627:therapeutic use
D000998:Antiviral Agents; D007166:Immunosuppressive Agents; D005719:gamma-Globulins; D007372:Interferons